Your browser doesn't support javascript.
loading
The phenotypic and genotypic spectrum of individuals with mono- or biallelic ANK3 variants.
Furia, Francesca; Levy, Amanda M; Theunis, Miel; Bamshad, Michael J; Bartos, Meghan N; Bijlsma, Emilia K; Brancati, Francesco; Cejudo, Lucile; Chong, Jessica X; De Luca, Chiara; Dean, Sarah Joy; Egense, Alena; Goel, Himanshu; Guenzel, Adam J; Hüffmeier, Ulrike; Legius, Eric; Mancini, Grazia M S; Marcos-Alcalde, Iñigo; Niclass, Tanguy; Planes, Marc; Redon, Sylvia; Ros-Pardo, David; Rouault, Karen; Schot, Rachel; Schuhmann, Sarah; Shen, Joseph J; Tao, Alice M; Thiffault, Isabelle; Van Esch, Hilde; Wentzensen, Ingrid M; Barakat, Tahsin Stefan; Møller, Rikke S; Gomez-Puertas, Paulino; Chung, Wendy K; Gardella, Elena; Tümer, Zeynep.
Afiliación
  • Furia F; Department of Epilepsy Genetics and Personalized Treatment, The Danish Epilepsy Centre, Dianalund, Denmark.
  • Levy AM; Faculty of Health Science, University of Southern Denmark (SDU), Odense, Denmark.
  • Theunis M; Department of Clinical Genetics, Kennedy Center, Copenhagen University Hospital, Copenhagen, Denmark.
  • Bamshad MJ; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium.
  • Bartos MN; Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, Washington, USA.
  • Bijlsma EK; Brotman-Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, USA.
  • Brancati F; Department of Pediatrics, Division of Genetic Medicine, Seattle Children's Hospital, Seattle, Washington, USA.
  • Cejudo L; Department of Genetics, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Chong JX; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
  • De Luca C; Human Genetics, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • Dean SJ; Human Functional Genetics Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Roma, Rome, Italy.
  • Egense A; CHU de Poitiers, Service de Génétique, Poitiers, France.
  • Goel H; Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, Washington, USA.
  • Guenzel AJ; Brotman-Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, USA.
  • Hüffmeier U; Human Genetics, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • Legius E; Department of Genetics, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Mancini GMS; Division of Genomic Medicine, Department of Pediatrics, University of California Davis, Sacramento, California, USA.
  • Marcos-Alcalde I; General Genetics Service, Hunter Genetics, Waratah, New South Wales, Australia.
  • Niclass T; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • Planes M; GeneDx Inc., Gaithersburg, Maryland, USA.
  • Redon S; Institute of Human Genetics, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany.
  • Ros-Pardo D; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium.
  • Rouault K; Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Schot R; ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Schuhmann S; Molecular Modeling Group, Centro de Biología Molecular Severo Ochoa (CBM, CSIC-UAM), Madrid, Spain.
  • Shen JJ; CHU de Poitiers, Service de Génétique, Poitiers, France.
  • Tao AM; Service de Génétique Clinique, CHRU de Brest, Brest, France.
  • Thiffault I; Service de Génétique Médicale et Biologie de la Reproduction, CHU de Brest, Brest, France.
  • Van Esch H; Université de Brest, INSERM, Etablissement Français du Sang, UMR 1078, Brest, France.
  • Wentzensen IM; Molecular Modeling Group, Centro de Biología Molecular Severo Ochoa (CBM, CSIC-UAM), Madrid, Spain.
  • Barakat TS; Service de Génétique Médicale et Biologie de la Reproduction, CHU de Brest, Brest, France.
  • Møller RS; Université de Brest, INSERM, Etablissement Français du Sang, UMR 1078, Brest, France.
  • Gomez-Puertas P; Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Chung WK; Discovery Unit, Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Gardella E; Institute of Human Genetics, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany.
  • Tümer Z; Division of Genomic Medicine, Department of Pediatrics, University of California Davis, Sacramento, California, USA.
Clin Genet ; 2024 Jul 11.
Article en En | MEDLINE | ID: mdl-38988293
ABSTRACT
ANK3 encodes ankyrin-G, a protein involved in neuronal development and signaling. Alternative splicing gives rise to three ankyrin-G isoforms comprising different domains with distinct expression patterns. Mono- or biallelic ANK3 variants are associated with non-specific syndromic intellectual disability in 14 individuals (seven with monoallelic and seven with biallelic variants). In this study, we describe the clinical features of 13 additional individuals and review the data on a total of 27 individuals (16 individuals with monoallelic and 11 with biallelic ANK3 variants) and demonstrate that the phenotype for biallelic variants is more severe. The phenotypic features include language delay (92%), autism spectrum disorder (76%), intellectual disability (78%), hypotonia (65%), motor delay (68%), attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) (57%), sleep disturbances (50%), aggressivity/self-injury (37.5%), and epilepsy (35%). A notable phenotypic difference was presence of ataxia in three individuals with biallelic variants, but in none of the individuals with monoallelic variants. While the majority of the monoallelic variants are predicted to result in a truncated protein, biallelic variants are almost exclusively missense. Moreover, mono- and biallelic variants appear to be localized differently across the three different ankyrin-G isoforms, suggesting isoform-specific pathological mechanisms.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Clin Genet Año: 2024 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Clin Genet Año: 2024 Tipo del documento: Article País de afiliación: Dinamarca